Evaluation of Endometrial Receptivity by Measuring HOXA-10, HOXA-11, and Leukemia Inhibitory Factor Expression in Patients with Polycystic Ovary Syndrome

---

Atıf İçin Kopyala

Kara M., SABAH ÖZCAN S., ARAN T., Kara O., YILMAZ N.

GYNECOLOGY AND MINIMALLY INVASIVE THERAPY-GMIT, cilt.8, sa.3, ss.118-122, 2019 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 8 Sayı: 3
• Basım Tarihi: 2019
• Doi Numarası: 10.4103/gmit.gmit_112_18
• Dergi Adı: GYNECOLOGY AND MINIMALLY INVASIVE THERAPY-GMIT
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
• Sayfa Sayıları: ss.118-122
• Yozgat Bozok Üniversitesi Adresli: Evet

Özet

Context: Polycystic ovary syndrome (PCOS) is an important cause of infertility. In women with PCOS have increased rate of spontaneous abortion and reduced rate of conception. HOXA-10 and HOXA-11 are proteinous products of homeobox gene group and play an important role during implantation.